|
|
|
While the opportunity for truly disease-modifying therapies has never been more exciting, the industry is struggling to find business models that ensure a
steady flow of innovative molecules offering compelling clinical and economic rationales.
Health Advances is working with pharmaceutical companies to usher in innovative approaches to new product planning. Incorporating internally and externally
sourced products, exploiting proteins as well as small molecules, and employing multi-indication development strategies as well as traditional life-cycle
management, we help companies explore all options for creating high value product portfolios.
- Product opportunity assessment
- Portfolio prioritization
- Clinical planning
- In-licensing
- Partnership strategy
- Corporate and business unit strategy
|
|
 |
|
|
|
|
|
 learn more
about our work with pharmaceutical companies.
|
|
|
|
|
 |
|
|
